One year follow up
| Placebo | Metoprolol | Celiprolol | |
|---|---|---|---|
| Number withdrawn | 10/10 (100%)6-150 | 6/19 (32%) | 9/21 (43%) |
| Mortality | 3/10 (30%) | 2/19 (11%) | 4/21 (19%) |
| NYHA class | 2.1 (0.7) | 2.1 (0.6) | 2.2 (0.5) |
| Echo: LVEDD (cm) | 6.24 (0.4) | 6.99 (0.34) | 6.38 (0.33) |
| FS (%) | 24.6 (1.5) | 18 (1.3) | 18 (1.5) |
| DT (ms) | 207 (19) | 190 (18) | 202 (19) |
Values are means (SEM) unless otherwise stated.
↵6-150 Seven placebo patients were transferred to β blocker treatment after completion of double blind study period and three continued with previous standard treatment.
DT, E wave deceleration time; FS, fractional shortening; LVEDD, left ventricular end diastolic dimension; NYHA, New York Heart Association.